Evaluationof PSMA-Targeted TREN-CAM Conjugates forTargeted Imaging of Cancer with <sup>68</sup>Ga(III) and <sup>45</sup>Ti(IV)

Chelation approaches that are compatible with a multitude of isotopes are an important area of development. Here, we introduce the design, synthesis, and evaluation of 2,3-dihydroxyterephthalate/catechol chelator conjugates compatible with the positron emission tomography (PET) isotopes <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup>, targeting the prostate-specific membrane antigen (PSMA). The conjugates are made in a multistep organic synthesis incorporating 2,3-dihydroxyterephthalate, linked to the amino hexanoic acid-extended, urea-dipeptides EuE or KuE (substrates of the PSMA active site). The radiochemical complexes, [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-EuE)]<sup>2–</sup>, [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-KuE)]<sup>2–</sup>, and [<sup>68</sup>Ga]­[Ga­(TREN-CAM-hex-KuE)]<sup>3–</sup> form readily at room temperature within 15 min with a molar activity of 24–29 mCi/μmol. The corresponding chelates are stable in phosphate-buffered saline (PBS) solution prior to injection. Subsequent in vivo studies in a bilateral tumor xenograft mouse model were conducted, including 90- and 270-min PET, followed by biodistribution and metabolite analysis at 2 or 5 h postinjection. These studies demonstrated selective uptake of the radiochemical complexes in the PSMA-expressing tumor (17.25 ± 4.15, 13.84 ± 3.85, 15.64 ± 6.37% ID/g for [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-EuE)]<sup>2–</sup>, [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-KuE)]<sup>2–</sup> and [<sup>68</sup>Ga]­[Ga­(TREN-CAM-hex-KuE)]<sup>3–</sup> respectively), with pharmacokinetics dominated by renal clearance. Delayed clearance of the [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-KuE)]<sup>2–</sup> complex is observed when compared with that of [<sup>68</sup>Ga]­[Ga­(TREN-CAM-hex-KuE)]<sup>3–</sup> as indicated by elevated activity retention in the blood, which we attribute to the charge difference and partial complex dissociation. Urine metabolite analysis shows that [<sup>68</sup>Ga]­[Ga­(TREN-CAM-hex-KuE)]<sup>3–</sup> is excreted >98% intact, while [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-KuE)]<sup>2–</sup> exhibited signs of dechelation. Conclusively, our data support further investigation of bifunctional TREN-CAM derivatives as a synthetically accessible bifunctional chelator class for <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup> isotopes.

Publication Details

Journal
Figshare
Published
2025-03-19
DOI
https://doi.org/10.1021/acs.bioconjchem.5c00099.s001
Primary Topic
Mycorrhizal Fungi and Plant Interactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluationof PSMA-Targeted TREN-CAM Conjugates forTargeted Imaging of Cancer with 68Ga(III) and 45Ti(IV)

Figshare
Mycorrhizal Fungi and Plant Interactions
article

Evaluationof PSMA-Targeted TREN-CAM Conjugates forTargeted Imaging of Cancer with 68Ga(III) and 45Ti(IV)

article en

Abstract

Chelation approaches that are compatible with a multitude of isotopes are an important area of development. Here, we introduce the design, synthesis, and evaluation of 2,3-dihydroxyterephthalate/catechol chelator conjugates compatible with the positron emission tomography (PET) isotopes <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup>, targeting the prostate-specific membrane antigen (PSMA). The conjugates are made in a multistep organic synthesis incorporating 2,3-dihydroxyterephthalate, linked to the amino hexanoic acid-extended, urea-dipeptides EuE or KuE (substrates of the PSMA active site). The radiochemical complexes, [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-EuE)]<sup>2–</sup>, [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-KuE)]<sup>2–</sup>, and [<sup>68</sup>Ga]­[Ga­(TREN-CAM-hex-KuE)]<sup>3–</sup> form readily at room temperature within 15 min with a molar activity of 24–29 mCi/μmol. The corresponding chelates are stable in phosphate-buffered saline (PBS) solution prior to injection. Subsequent in vivo studies in a bilateral tumor xenograft mouse model were conducted, including 90- and 270-min PET, followed by biodistribution and metabolite analysis at 2 or 5 h postinjection. These studies demonstrated selective uptake of the radiochemical complexes in the PSMA-expressing tumor (17.25 ± 4.15, 13.84 ± 3.85, 15.64 ± 6.37% ID/g for [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-EuE)]<sup>2–</sup>, [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-KuE)]<sup>2–</sup> and [<sup>68</sup>Ga]­[Ga­(TREN-CAM-hex-KuE)]<sup>3–</sup> respectively), with pharmacokinetics dominated by renal clearance. Delayed clearance of the [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-KuE)]<sup>2–</sup> complex is observed when compared with that of [<sup>68</sup>Ga]­[Ga­(TREN-CAM-hex-KuE)]<sup>3–</sup> as indicated by elevated activity retention in the blood, which we attribute to the charge difference and partial complex dissociation. Urine metabolite analysis shows that [<sup>68</sup>Ga]­[Ga­(TREN-CAM-hex-KuE)]<sup>3–</sup> is excreted >98% intact, while [<sup>45</sup>Ti]­[Ti­(TREN-CAM-hex-KuE)]<sup>2–</sup> exhibited signs of dechelation. Conclusively, our data support further investigation of bifunctional TREN-CAM derivatives as a synthetically accessible bifunctional chelator class for <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup> isotopes.

Figshare
Openalex Percentile: Top 55%
Mycorrhizal Fungi and Plant Interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.